"I have Bi Polar Type 2 (not officially diagnosed as my GP had already started my treatment on mood stabiliser Olanzapine) I am diagnosed as having Major depression, I’m on…
Major depressive disorder (MDD) is a significant cause of disability worldwide and the most common illness preceding suicide. On March 5, 2019, the nasal spray drug, esketamine, also known as Spravato (by Janssen…
Spravato is the brand name of esketamine, a glutamate receptor drug used for rapid depression treatment manufactured by Johnson & Johnson in the US. Esketamine is contained within the standard pharmaceutical…